Optimizing Immunotherapy

Overview

As immunotherapy continues to evolve, healthcare professionals must navigate advances in treatment selection, administration, monitoring, and supportive care. Emerging clinical evidence, new therapeutic formulations, and a growing understanding of biomarkers are creating opportunities to refine treatment strategies and optimize outcomes across oncology practice.

This section provides evidence-based information and practical considerations to support the clinical use of immunotherapy. Topics include subcutaneous immune checkpoint inhibitors, genomic and biomarker testing, treatment response assessment, immune-related adverse event management, and strategies for addressing barriers to care.

Resources explore both the scientific evidence informing treatment decisions and the operational considerations involved in translating advances into clinical practice, including patient selection, treatment administration, safety monitoring, and institutional workflows.

Designed for oncology healthcare professionals across academic and community practice settings, Optimizing Immunotherapy brings together clinical insights and educational resources to support informed decision-making and the effective integration of evolving immunotherapy approaches into cancer care.